Diagnosis of DSM-IV-TR [52] of Bipolar I or Bipolar II disorder as verified by the semi-structured diagnostic interviews SCID [37] or MINI plus [36]. The diagnosis may be supported by information from significant others, and from hospital records. Angst's hypomania checklist [53] is used to increase the detection of hypomanic symptoms. SCID or MINI plus will be used to diagnose the patient. |
ECT is indicated. |
Severity: meet DSM-IV-TR criteria of depressive episode, MADRS [40] of 25 or above |
Treatment resistance: None response to two trials (during lifetime) with mood stabilizers with proven efficacy in bipolar depression (lithium, lamotrigine, quetiapine, olanzapine) and/or antidepressants. |
A trial is defined as at least 6 weeks in adequate or tolerated dose as reported by the patient, or patients that have been unable to comply with 6 weeks trials of mood stabilizer or an antidepressant. |
None response: Less than 50% reduction in MADRS values or still meet DSM -IV-TR criteria of depressive episode |
Inpatients the first week after start of treatment condition |
The patients are to be treated by the psychiatrist at the hospital for the whole duration of the study (6 weeks) |
Age ≥ 18 |
Patient competent to give informed consent according to the judgement of the clinician |
Written informed consent |
Patient sufficiently fluent in Norwegian language to ensure valid responses to psychometric testing (for patients enrolled to neuropsychological assessment: Norwegian as primary language or 12 years attendance of a Norwegian school) |